Dashboard
Manage Tickers

CRISCURIS INC

Nasdaq curis.com


$ 16.37 $ -0.79 (-4.78 %)    

Thursday, 09-May-2024 15:58:11 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 15.72
$ 16.74
$ 0.00 x 0
$ 0.00 x 0
$ 16.37 - $ 16.74
$ 3.80 - $ 19.60
12,065
na
90.92M
$ 0.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-08-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-13-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-16-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-19-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-26-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 03-08-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 03-09-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 02-24-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-curis-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Curi...
05/08/2024 10:31:36

HC Wainwright & Co. analyst Edward White reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $26 price target.

curis-q1-eps-205-beats-212-estimate-sales-209m-miss-240m-estimate
Curis Q1 EPS $(2.05) Beats $(2.12) Estimat...
05/07/2024 12:01:35

Curis (NASDAQ:CRIS) reported quarterly losses of $(2.05) per share which beat the analyst consensus estimate of $(2.12) by 3.3 ...

top-3-health-care-stocks-that-may-collapse-in-q2
Top 3 Health Care Stocks That May Collapse...
04/12/2024 12:34:00

As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum a...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
04/04/2024 16:31:14

cyberark-software-to-rally-around-19-here-are-10-top-analyst-forecasts-for-friday
CyberArk Software To Rally Around 19%? Her...
02/09/2024 13:11:00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

hc-wainwright--co-maintains-buy-on-curis-lowers-price-target-to-26
HC Wainwright & Co. Maintains Buy on Curis...
02/09/2024 11:07:31

HC Wainwright & Co. analyst Edward White maintains Curis (NASDAQ:CRIS) with a Buy and lowers the price target from $51 t...

curis-said-may-offer-sell-shares-of-common-stock-from-time-to-time-in-one-or-more-offerings-of-up-to-300m-in-aggregate-offering-price
Curis Said May Offer, Sell Shares Of Commo...
02/08/2024 21:35:32

-S-3

as-of-december-31-2023-curiss-cash-cash-equivalents-and-investments-totaled-563m-curis-expects-its-existing-cash-cash-equivalents-and-investments-should-enable-its-planned-operations-into-2025
As Of December 31, 2023, Curis's Cash, Cas...
02/08/2024 13:02:30

curis-q4-eps-203-beats-211-estimate-sales-270m-miss-302m-estimate
Curis Q4 EPS $(2.03) Beats $(2.11) Estimat...
02/08/2024 13:01:38

Curis (NASDAQ:CRIS) reported quarterly losses of $(2.03) per share which beat the analyst consensus estimate of $(2.11) by 3.79...

earnings-scheduled-for-february-8-2024
Earnings Scheduled For February 8, 2024
02/08/2024 09:43:03

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

curiss-earnings-a-preview
Curis's Earnings: A Preview
02/07/2024 20:01:47

why-blackberry-shares-are-trading-lower-by-over-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why BlackBerry Shares Are Trading Lower By...
01/24/2024 18:05:27

Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private ...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/24/2024 17:31:02

curis-announces-initial-combination-study-data-from-its-takeaim-lymphoma-study
Curis Announces Initial Combination Study ...
12/12/2023 13:19:22

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, sm...

curis-presented-clinical-data-from-the-takeaim-leukemia-study-at-the-2023-ash-conference
Curis Presented Clinical Data From The Tak...
12/11/2023 13:09:24

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, sm...

curis-announces-three-presentations-at-ash
Curis Announces Three Presentations At ASH
12/06/2023 13:11:54

PresentationsTakeAim LeukemiaAbstract Title: Preliminary Safety and Efficacy of Emavusertib (CA-4948) in Acute Myeloid Leukemia...

curis-enters-into-agreement-for-emavusertib--pembrolizumab-combination-study-in-melanoma
Curis Enters Into Agreement For Emavuserti...
12/05/2023 13:02:25

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, sm...

why-genesco-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Genesco Shares Are Trading Lower By Ar...
12/01/2023 17:04:40

Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday.

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
11/29/2023 13:06:56

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
11/22/2023 13:06:47

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION